biomarker Archives - Page 2 of 3

Germany Poland UKSANO: Centre for New Methods in Computational Diagnostics and Personalised Therapy

July 19, 2022by pcdata

Dates: 01/08/2019 31/07/2026 Topic: Research Centre AI/Big Data Project type: Preclinic Project target: Other Financing: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions Participating agents: SANO CENTRUM ZINDYWIDUALIZOWANEJ MEDYCYNY OBLICZENIOWEJ MIEDZYNARODOWA FUNDACJA BADAWCZA Keywords: data science; productivity; catalysis; digital tool; centre; biomarker; AI Countries: Poland; Germany; UK Project page: Access page...

CyprusMechanical Biomarkers for Prediction of Cancer Immunotherapy

July 19, 2022by pcdata

Dates: 01/04/2020 31/03/2025 Topic: Biomarkers identification Project type: Immunotherapy Preclinic Clinic Theranostic Project target: Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: UNIVERSITY OF CYPRUS Keywords: biomarker; oncology; tumour; immunotherapy; model; biomechanic Countries: Cyprus Project page: Access page

ItalyAmplificatioN Free Identification of cancer and viral biomarkers via plasmonic nanoparticles and liquid BIOpsy

July 19, 2022by pcdata

Dates: 01/06/2021 31/05/2026 Topic: Biomarkers identification Tool Project type: Preclinic Theranostic Project target: Prostate Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: POLITECNICO DI TORINO Keywords: liquid biopsy; biomarker; cancer; influenza A; RNA; nano-material; machine-learning; SERS; surface enhanced Raman scattering; nano particles Countries: Italy Project page: Access page

Belgium Denmark France Germany Hungary Netherlands Norway Switzerland UKMICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response

July 19, 2022by pcdata

Dates: 01/01/2019 31/03/2025 Topic: Biomarkers identification Tool AI/Big Data Project type: Preclinic Clinic Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF) Keywords: liver cihrrosis; biomarker; clinical trial; ACLF; acute-on-chronic liver failure; OMICs; hepatology;...

SwitzerlandMultiple sclerosis immune cell characterisation to provide new disease biomarker

July 19, 2022by pcdata

Dates: 01/012021 31/12/2025 Topic: Biomarkers identification Project type: Preclinic Immunotherapy Project target: Autoimmune disease Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: UNIVERSITAT ZURICH Keywords: Neurobiology; MS; inflammatory disease; stem cell; biomarker; mapping; twin pair Countries: Switzerland Project page: Access page

GermanyPredicting potent drug combinations by exploiting monotherapy resistance

July 19, 2022by pcdata

Dates: 01/01/2021 31/12/2025 Topic: Biomarkers identification AI/Big data Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH Keywords: Prostate cancer; colorectal cancer; drug resistance; reinforcement; tumour; biomarker; HTS; QSAR; monotherapy Countries: Germany Project page: Access...

GermanyTargeting the crosstalk of lipid and glucose metabolism to stop cancer-associated wasting

July 19, 2022by pcdata

Dates: 01/05/2021 30/04/2026 Topic: Biomarkers identification Project type: Preclinic Theranostic Project target: Digestive disease Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH Keywords: cachexia; cancer; tumour; biomarker; adipocyte; adipose tissue; OMICs; metabolism; glucose; lipid Countries: Germany Project page: Access page

Belgium France Germany Ireland Israel Italy Netherlands Portugal South Africa Spain Sweden Switzerland UK USAAutism Innovative Medicine Studies 2 Trials

July 19, 2022by pcdata

Dates: 01/06/2018 31/05/2023 Topic: Biomarkers identification Procedures Project type: Preclinic Clinic Project target: Neurology Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being MAIN PROGRAMME H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: KING’S COLLEGE LONDON Keywords: Autism Spectrum Disorder; clinical trial; biomarker; procedures; network; consortium Countries: UK; Switzerland; Netherlands; Spain;...

Canada France Germany Netherlands Sweden Switzerland UK USAEUbOPEN: Enabling and Unlocking biology in the OPEN

July 19, 2022by pcdata

Dates: 01/05/2020 30/04/2025 Topic: Biomarkers identification AI/Big data Project type: Preclinic Theranostic Project target: Cancer Neurology Digestive disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN Keywords: biomarker; drug; library; genome; neurodegeneration; cancer; bowel disease; solute...

France Greece Netherlands Spain Switzerland USAHost-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Strategies Project type: Preclinic Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES Keywords: hospital-acquired pneumonia; pneumonology; antibiotic; infectious disease; drug resistance; biomarker; strategy; OMICs; clinical trial; procedure Countries:...

Newer Posts

Older Posts